PaxMedica, Inc. Announces Third Quarter 2023 Financial Results and Business Update
TARRYTOWN, NY / ACCESSWIRE / November 15, 2023 / PaxMedica, Inc. (NASDAQ:PXMD), a biopharmaceutical company focused on advancing treatments for...
Pharmaceutical
Canada’s Actuaries Support Drug Coverage for All Canadians by Improving Existing Systems
Ottawa, Ontario--(Newsfile Corp. - November 15, 2023) - The Canadian Institute of Actuaries (CIA) supports the federal government's objective to...
FSD Pharma Files Supplement to Management Information Circular in Connection with Special Meeting to be Held on November 20, 2023
TORONTO, ON / ACCESSWIRE / November 15, 2023 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical...
CNS Pharmaceuticals Reports Third Quarter 2023 Financial Results and Reiterates Company is on Track to Achieve Milestones for Berubicin Potentially Pivotal Study Before Year End
- Enrollment numbers rise to 239 in ongoing potentially pivotal study of Berubicin for treatment of GBM; Expected full enrollment...
Envision Pharma Group Announces New AI Innovation Board and Appoints Chairwoman
The new board and leadership appointment aligns with the company's commitment to advancing the industry through innovation and the expansion...
NanoViricides Has Filed its Quarterly Report – NV-387 Broad-Spectrum Antiviral in Clinical Trials Has Additional Applications
SHELTON, CT / ACCESSWIRE / November 15, 2023 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), reports that it has filed...
USDA-APHIS Determines that Yield10 Bioscience’s Stacked Herbicide Tolerant Camelina May Be Planted and Bred in the United States
-Herbicide Technology Critical to Enabling Large-Acreage Adoption of Camelina in North AmericaWOBURN, Mass., Nov. 15, 2023 (GLOBE NEWSWIRE) -- Yield10 Bioscience,...
USDA-APHIS Determines that Yield10 Bioscience’s Glufosinate Tolerant Camelina May Be Planted and Bred in the United States
-Yield10 Achieves a Significant Milestone in the Development of Camelina as a Commercial Crop for Producing Biofuels and Omega-3 Oils -On...
BioNxt Reports on New Cladrabine ODF Product Development and Commercialization Program
VANCOUVER, BC / ACCESSWIRE / November 15, 2023 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT) is pleased to...
Scientific Industries Reports Financial Results for Third Quarter 2023
Bioprocessing Operations Launched Revolutionary New ProductsBioprocessing Revenue Generated From Legacy Products Up 36%Vivid Pill Counters YTD Revenue Up 75%BOHEMIA, NY...
Elite Pharmaceuticals, Inc. Reports Financial Results for Second Quarter of Fiscal Year 2024 ended September 30, 2023 and Provides Conference Call Information
Conference Call Scheduled for Wednesday, November 15 at 11:30 AM ESTNORTHVALE, NJ / ACCESSWIRE / November 14, 2023 / Elite...
Aytu BioPharma Reports Fiscal 2024 First Quarter Financial Results
Q1 2024 Adjusted EBITDA of $2.2 millionRx Segment net revenue of $17.8 million and Adjusted EBITDA of $2.4 million in...
Avenir Wellness Solutions Reports Third Quarter 2023 Results
New Campaigns Showing Encouraging ResultsSHERMAN OAKS, CA / ACCESSWIRE / November 14, 2023 / Avenir Wellness Solutions, Inc. (OTCQB:AVRW) ("Avenir"...
Humanetics Corporation Appoints Dr. Colin Chinn as Chief Medical Officer
Dr. Chinn retired as a Rear Admiral of the United States NavyMINNEAPOLIS--(BUSINESS WIRE)--Humanetics Corporation, a leading innovator in medical countermeasures,...
Incite Health, Inc. Introduces Pharmacogenomics Services to Improve the Safety, Efficacy, and Efficiency of Clinical Trials
New innovative clinical services to help pharmaceutical and biotech companies improve patient recruitment, reduce the risk of adverse reactions, and...
GE HealthCare to Hold Fireside Chat with Citi Medtech Analyst at RSNA 2023
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC), is announcing today that President and Chief Executive Officer, Peter Arduini, and Vice President and...
Jaguar Health Reports Third Quarter 2023 Financial Results
Net revenue increased 5% in Q3 2023 versus Q2 2023Top line results expected before Thanksgiving for company's phase 3 OnTarget...
Reveal HealthTech Partners with CancerX and the CancerX Accelerator Program to Drive Cancer Innovation
NEW YORK, NY / ACCESSWIRE / November 14, 2023 / Reveal HealthTech, a leading healthcare technology company, today announced a...
CureVac Announces Financial Results for the Third Quarter and First Nine Months of 2023 and Provides Business Update
CureVac Announces Financial Results for the Third Quarter and First Nine Months of 2023 and Provides Business UpdateEnrollment completed for...
NeoGenomics to Participate at the Piper Sandler 35th Annual Healthcare Conference
FT. MYERS, FL / ACCESSWIRE / November 14, 2023 / NeoGenomics, Inc. (NASDAQ:NEO), a leading oncology testing services company, today...